Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 11:56 PM
Study NCT ID:
NCT03568994
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-21
First Post:
2018-05-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Atovaquone (Mepron®) Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML)
Sponsor:
Baylor College of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-10
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-05-31
First Submit QC Date:
None
Study First Post Date:
2018-06-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-19
Last Update Post Date:
2024-11-21
Last Update Post Date Type:
ACTUAL